Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Staar Surgical CoSTAA -2.40%76 Days Sales Outstanding is 87.63 as of Jun. 2026, which is 25% above its 10-year median of 70.04. GuruFocus rates STAA with a GF Score™ of 76/100 and a GF Value™ of $33.37 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 811 Medical Devices & Instruments companies, Staar Surgical Co ranks worse than 54.75% on this metric.
The historical rank and industry rank for Staar Surgical Co's Days Sales Outstanding or its related term are showing as below:
STAA'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 62.37 Med: 70.04 Max: 100.35
Current: 69.7
During the past 13 years, Staar Surgical Co's highest Days Sales Outstanding was 100.35. The lowest was 62.37. And the median was 70.04.
STAA's Days Sales Outstanding is ranked worse than 54.75% of 811
companies
in the Medical Devices & Instruments industry
Industry Median: 65.38
vs STAA: 69.70
Staar Surgical Co's Days Sales Outstanding
increased
from Jun. 2025 (76.58) to Jun. 2026 (87.63).
Staar Surgical Co (NAS:STAA) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Staar Surgical Co Days Sales Outstanding Related Terms
Staar Surgical Co Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Staar Surgical Co's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STAA vs AZTA, KMTS, ANGO: Days Sales Outstanding Comparison
For the Medical Instruments & Supplies subindustry, Staar Surgical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Staar Surgical Co Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Staar Surgical Co's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Staar Surgical Co's Days Sales Outstanding falls into.
Staar Surgical Co Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Staar Surgical Co (STAA) has a Days Sales Outstanding of 87.63 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Staar Surgical Co and its competitors. This is 25% above median its historical median of 70.04. Over the past decade, Staar Surgical Co's Days Sales Outstanding has ranged from 62.37 to 100.35. According to the industry distribution chart, Staar Surgical Co ranks #444 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 54.7%.
Is Staar Surgical Co's Days Sales Outstanding too high?
Staar Surgical Co's current Days Sales Outstanding of 87.63 is 25% above median its 10-year median of 70.04. Over the past 10 years, this metric has ranged from a low of 62.37 to a high of 100.35. The Medical Devices & Instruments industry median Days Sales Outstanding is 65.38. Staar Surgical Co's value of 87.63 is 34% above this industry median. Based on the distribution chart, Staar Surgical Co ranks #444 out of 811 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Staar Surgical Co has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Staar Surgical Co's Days Sales Outstanding compare to AZTA and KMTS?
According to the Medical Devices & Instruments industry distribution chart, Staar Surgical Co ranks #444 out of 811 companies for Days Sales Outstanding. This places Staar Surgical Co in the lower half of its industry. The industry median Days Sales Outstanding is 65.38. Staar Surgical Co's value of 87.63 is 34% above this benchmark. Historically, Staar Surgical Co's own Days Sales Outstanding has ranged from 62.37 to 100.35 over the past decade. While the company's 10-year median is 70.04 vs. the industry median of 65.38, Staar Surgical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.38, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Staar Surgical Co's current Days Sales Outstanding of 87.63 is 34% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Staar Surgical Co and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Staar Surgical Co's current Days Sales Outstanding is 87.63, which is 25% above median its own 10-year median of 70.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Staar Surgical Co stock overvalued right now?
Based on GuruFocus' analysis, Staar Surgical Co (STAA) is currently considered Possible Value Trap. The stock's GF Value™ is $33.37, compared to a current price of $20.32 — trading 39.1% below its estimated fair value. The current Days Sales Outstanding is 87.63, which is 25% above median its 10-year median of 70.04 and 34% above the Medical Devices & Instruments industry median of 65.38. Staar Surgical Co's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Staar Surgical Co (STAA), the current Days Sales Outstanding is 87.63 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Staar Surgical Co (STAA) Overvalued in 2026?
Based on GuruFocus' analysis, Staar Surgical Co stock appears to be undervalued.
The current stock price of $20.32 is trading 39.1% below its estimated GF Value™ of $33.37.
GuruFocus considers Staar Surgical Co to be Possible Value Trap.
Key valuation signals for STAA:
Days Sales Outstanding: 87.63 (25% above median its 10-year median of 70.04)
GF Value™: $33.37 vs. price of $20.32 (39.1% below fair value)
Industry Position: 34% above the Medical Devices & Instruments median (#444 of 811)
No single metric tells the full story. See the STAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
76GF Score
Get the complete analysis for STAA
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STAA has been successfully added to your 
